... and the German Cancer Research Center have discovered this correlation. With this new set of tumor markers, the intensity of treatment can be adjusted individually and the potentially damaging effects ...
... of disease relapse are. Researchers have discovered this correlation. With this new set of tumor markers, the intensity of treatment can be adjusted individually and the potentially damaging effects ...
... fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide ...
... the CTC assay is a more reliable means of assessing treatment response than the traditional tumor markers currently in use.
“We have a follow-up study underway that evaluates CTC results within the ...
... is highly expressed in some tumor cell lines and could be very useful as a tumor marker, Giordano said. A protein isoform is a version of a protein with only small differences to another isoform of ...
... we know about Herceptin resistance, including other mutations, alterations in specific markers. If other tumor markers of resistance are found in these patients, explains Mittendorf, then it would ...
... . The ELLA Binational Breast Cancer Study: Risk factor and tumor marker profile in women of Mexican ancestry.
The first abstract will be presented by Maria M. Meza-Montenegro, Ph.D ...
Scientists have developed a potential new treatment for patients with prostate cancer. They have produced a monoclonal antibody to a unique tumor marker for the treatment of prostate cancer.
... do just that.
Cima and his colleagues recently reported that their device successfully tracked a tumor marker in mice for one month. The work is described in a paper published online in the journal ...
... and found that patients with extrahepatic disease, high levels of carcinoembriogenic antigen (a commonly used tumor marker for colorectal cancer patients' surveillance) or more than 4 nodules were at ...
... rely on new molecular imaging methods or fluid samples from the uterus or vagina — in which tumor markers are likely to be more concentrated.
The research will be published in the July 28 issue of ...
... a lack of reproducibility and reliability among retrospective studies, and low insurance reimbursements for tumor marker tests. In the case of biomarkers for guiding the use of already approved drugs, ...
